{
    "2018-01-30": [
        [
            {
                "time": "",
                "original_text": "一财研选｜阿里腾讯巨资参与万达私有化，“新零售”站上行业风口！",
                "features": {
                    "keywords": [
                        "阿里",
                        "腾讯",
                        "万达",
                        "私有化",
                        "新零售"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "零售",
                        "科技",
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级] 医药行业周报：把握结构性机会 重点关注意创新和高端仿制",
                "features": {
                    "keywords": [
                        "医药",
                        "行业周报",
                        "结构性机会",
                        "创新",
                        "高端仿制"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级] 医药生物行业景气度前瞻之二：医药外包：春江水暖鸭先知",
                "features": {
                    "keywords": [
                        "医药生物",
                        "景气度",
                        "医药外包"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}